Sangamo Therapeutics Company

Sangamo is a clinical stage biopharmaceutical company focused on the research, development and commercialization of engineered zinc finger DNA-binding proteins (ZFPs) as novel ZFP Therapeutics targeting various monogenic and infectious diseases with unmet medical needs.
Technology: End-to-end Drug Development
Industry: Advanced R&D
Headquarters: USA
Founded Date: 1995

Visit Website
Register and Claim Ownership